Literature DB >> 33153671

Bone Health in Childhood Chronic Disease.

David R Weber1.   

Abstract

Many children with chronic disease are now surviving into adulthood. As a result, there is a growing interest in optimizing bone health early in the disease course with the dual goals of improving quality of life during childhood and reducing life-long fracture risk. Risk factors for impaired bone health in these children include immobility, nutritional deficiency, exposure to bone toxic therapies, hormonal deficiencies affecting growth and pubertal development, and chronic inflammation. This review focuses on the chronic diseases of childhood most commonly associated with impaired bone health. Recent research findings and clinical practice recommendations, when available, for specific disorders are summarized.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bisphosphonate; Bone density; Bone health; Dual-energy x-ray absorptiometry; Fracture; Osteoporosis

Year:  2020        PMID: 33153671      PMCID: PMC7664841          DOI: 10.1016/j.ecl.2020.07.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  86 in total

1.  The effect of the ketogenic diet on the developing skeleton.

Authors:  Peter J Simm; Jillian Bicknell-Royle; Jock Lawrie; Judy Nation; Kellie Draffin; Karen G Stewart; Fergus J Cameron; Ingrid E Scheffer; Mark T Mackay
Journal:  Epilepsy Res       Date:  2017-07-26       Impact factor: 3.045

2.  Unexpected widespread hypophosphatemia and bone disease associated with elemental formula use in infants and children.

Authors:  Luisa F Gonzalez Ballesteros; Nina S Ma; Rebecca J Gordon; Leanne Ward; Philippe Backeljauw; Halley Wasserman; David R Weber; Linda A DiMeglio; Julie Gagne; Robert Stein; Declan Cody; Kimber Simmons; Paul Zimakas; Lisa Swartz Topor; Sungeeta Agrawal; Andrew Calabria; Peter Tebben; Ruth Faircloth; Erik A Imel; Linda Casey; Thomas O Carpenter
Journal:  Bone       Date:  2017-02-04       Impact factor: 4.398

3.  Pamidronate Treatment to Prevent Reoccurring Fractures in Children With Cerebral Palsy.

Authors:  Julieanne P Sees; Prakash Sitoula; Kirk Dabney; Laurens Holmes; Kenneth J Rogers; Heidi H Kecskemethy; Steven Bachrach; Freeman Miller
Journal:  J Pediatr Orthop       Date:  2016-03       Impact factor: 2.324

4.  Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.

Authors:  Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen
Journal:  J Clin Endocrinol Metab       Date:  2017-11-01       Impact factor: 5.958

5.  Bone Mineral Density of Very Long-term Survivors After Childhood Liver Transplantation.

Authors:  Looi C Ee; Charlton Noble; Jonathan Fawcett; Geoffrey J Cleghorn
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-05       Impact factor: 2.839

6.  Increases in IGF-1 After Anti-TNF-α Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease.

Authors:  Mark D DeBoer; Arthur M Lee; Kirabo Herbert; Jin Long; Meena Thayu; Lindsay M Griffin; Robert N Baldassano; Lee A Denson; Babette S Zemel; Michelle R Denburg; Rita Herskovitz; Mary B Leonard
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

Review 7.  Bone Health and Osteoporosis Management of the Patient With Duchenne Muscular Dystrophy.

Authors:  Leanne M Ward; Stasia Hadjiyannakis; Hugh J McMillan; Garey Noritz; David R Weber
Journal:  Pediatrics       Date:  2018-10       Impact factor: 7.124

8.  Intravenous bisphosphonate therapy in children with spinal muscular atrophy.

Authors:  N Nasomyont; L N Hornung; H Wasserman
Journal:  Osteoporos Int       Date:  2019-12-02       Impact factor: 4.507

9.  Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate.

Authors:  Maria Luisa Bianchi; Carla Colombo; Baroukh M Assael; Antonella Dubini; Mariangela Lombardo; Serena Quattrucci; Sergio Bella; Mirella Collura; Barbara Messore; Valeria Raia; Furio Poli; Rita Bini; Carlina V Albanese; Virginia De Rose; Diana Costantini; Giovanna Romano; Elena Pustorino; Giuseppe Magazzù; Serenella Bertasi; Vincenzina Lucidi; Gabriella Traverso; Anna Coruzzo; Amelia D Grzejdziak
Journal:  Lancet Respir Med       Date:  2013-06-02       Impact factor: 30.700

10.  Clinical Guidelines for Management of Bone Health in Rett Syndrome Based on Expert Consensus and Available Evidence.

Authors:  Amanda Jefferson; Helen Leonard; Aris Siafarikas; Helen Woodhead; Sue Fyfe; Leanne M Ward; Craig Munns; Kathleen Motil; Daniel Tarquinio; Jay R Shapiro; Torkel Brismar; Bruria Ben-Zeev; Anne-Marie Bisgaard; Giangennaro Coppola; Carolyn Ellaway; Michael Freilinger; Suzanne Geerts; Peter Humphreys; Mary Jones; Jane Lane; Gunilla Larsson; Meir Lotan; Alan Percy; Mercedes Pineda; Steven Skinner; Birgit Syhler; Sue Thompson; Batia Weiss; Ingegerd Witt Engerström; Jenny Downs
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more
  3 in total

Review 1.  Friedreich ataxia: clinical features and new developments.

Authors:  Medina Keita; Kellie McIntyre; Layne N Rodden; Kim Schadt; David R Lynch
Journal:  Neurodegener Dis Manag       Date:  2022-06-29

2.  An update on methods for assessing bone quality and health in Cystic fibrosis.

Authors:  Kristen M Williams; Amy Darukhanavala; Rebecca Hicks; Andrea Kelly
Journal:  J Clin Transl Endocrinol       Date:  2021-12-06

3.  Prevalence of osteopathologies in a single center cohort of survivors of childhood primary brain tumor.

Authors:  Michael M Schündeln; Sebastian Fritzemeier; Sarah C Goretzki; Pia K Hauffa; Martin Munteanu; Cordula Kiewert; Berthold P Hauffa; Gudrun Fleischhack; Stephan Tippelt; Corinna Grasemann
Journal:  Front Pediatr       Date:  2022-07-18       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.